Using Virtual Reality to Reduce Procedural Pain in Children With Cancer

Titre officiel

Using Virtual Reality to Reduce Procedural Pain in Children With Cancer: A Pilot Randomized Controlled Trial

Sommaire:

Cette étude évaluera les effets de l’utilisation de la réalité virtuelle (RV) sur la diminution de la douleur liée à la mise en place d’un accès sous-cutané implantable chez les enfants atteints de cancer. L’étude est un essai pilote contrôlé à répartition aléatoire (ECRA) à méthodologie croisée qui nous fournira des renseignements détaillés sur la faisabilité de la mise en œuvre de notre protocole dans le cadre d’un ECRA multicentrique futur ainsi qu’une estimation préliminaire de l’effet thérapeutique de l’utilisation de la RV chez les enfants atteints de cancer subissant la mise en place d’un accès sous-cutané implantable, y compris les facteurs chez l’enfant et les parents favorisant potentiellement l’efficacité de la RV à titre de traitement de distraction.

Description de l'essai

Primary Outcome:

  • Accural Rates/Retention Rates
  • Acceptability
  • Outcome measure feasibility
  • Technical Difficulties/Practical Difficulties
Secondary Outcome:
  • Pain Intensity
  • Child Distress
  • Child Fear
  • Child Pain Catastrophizing
  • Parent Pain Catastrophizing
  • Parent Distress
The study is a repeated-measures cross-over pilot RCT to examine the feasibility of the trial protocol for a study into the effectiveness of immersive VR in minimizing procedural pain and distress in children with cancer. The research objectives are to: (1) pilot implementing immersive virtual reality (VR) for effectiveness testing in a future RCT (measured as implementation outcomes); (2) determine treatment effect sizes (measured as preliminary effectiveness outcomes), between VR, programmed to distract children during an SCP needle insertion, and an active control intervention (i.e., watching a video with headphones); and (3) assess impact of child and parent factors potentially associated with VR treatment effectiveness. Both the intervention and control groups will receive standard medical care (e.g., topical anesthetics). A convenience sample of 40 children and adolescents with cancer (20 participants per treatment arm; 10 boys and 10 girls per treatment arm) will be recruited. In addition, each child will act as their own control. A washout period of 1 month will be used to control for any carry-over effect between conditions. In addition to usual care, children in the experimental condition will wear the VR headset plus headphones. In the control condition, children will watch a video (i.e., an age-appropriate video selected by an oncology-affiliated child life specialist) on an iPad, while wearing the same headphones as in the experimental condition. Implementation outcomes include accrual and retention rates, acceptability and technical difficulties. Effectiveness outcomes include child pain, distress, and fear, as well as parent distress.

Voir cet essai sur ClinicalTrials.gov

Intéressé(e) par cet essai?

Imprimez cette page et apportez-la chez votre médecin pour discuter de votre admissibilité à cet essai et des options de traitement. Seul votre médecin peut vous recommander pour un essai clinique.

Ressources

Société canadienne du cancer

Ces ressources sont fournies en partenariat avec Société canadienne du cancer